ECM
SAGE

Eisler Capital Management’s Sage Therapeutics SAGE Stock Holding History

Eisler Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-330,150
Closed -$3.01M – 944
2025
Q2 		$3.01M Buy
330,150
+160,150
+94% +$1.18M 0.02% 477
2025
Q1 		$1.35M Buy
+170,000
New +$1.24M 0.01% 672

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eisler Capital Management's SAGE Position: Q3 2025 in Review

Eisler Capital Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 330,150 shares — an estimated $3.01M sold.

Eisler Capital Management first reported a position in SAGE in Q1 2025 and held it in 2 quarters. The position peaked at $3.01M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Eisler Capital Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Eisler Capital Management sold 330,150 Sage Therapeutics shares in Q3 2025, an estimated $3.01M.
  • Eisler Capital Management first reported a position in Sage Therapeutics in Q1 2025 and held it in 2 quarters.
  • Eisler Capital Management's Sage Therapeutics position peaked at $3.01M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.